SUPER GROUP SGHC LTD (SGHC) Fundamental Analysis & Valuation

NYSE:SGHC • GG00BMG42V42

Current stock price

12.24 USD
-0.16 (-1.29%)
At close:
12.25 USD
+0.01 (+0.08%)
After Hours:

This SGHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SGHC Profitability Analysis

1.1 Basic Checks

  • In the past year SGHC was profitable.
  • Of the past 5 years SGHC 4 years were profitable.
  • SGHC had a positive operating cash flow in each of the past 5 years.
SGHC Yearly Net Income VS EBIT VS OCF VS FCFSGHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

  • SGHC's Return On Assets of 11.90% is amongst the best of the industry. SGHC outperforms 87.30% of its industry peers.
  • Looking at the Return On Equity, with a value of 19.98%, SGHC belongs to the top of the industry, outperforming 80.16% of the companies in the same industry.
  • SGHC has a better Return On Invested Capital (34.32%) than 97.62% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SGHC is significantly above the industry average of 10.55%.
  • The last Return On Invested Capital (34.32%) for SGHC is above the 3 year average (15.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.9%
ROE 19.98%
ROIC 34.32%
ROA(3y)10.16%
ROA(5y)16.96%
ROE(3y)17.87%
ROE(5y)59.56%
ROIC(3y)15.79%
ROIC(5y)31.82%
SGHC Yearly ROA, ROE, ROICSGHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

  • SGHC's Profit Margin of 6.41% is fine compared to the rest of the industry. SGHC outperforms 65.08% of its industry peers.
  • SGHC's Profit Margin has declined in the last couple of years.
  • The Operating Margin of SGHC (15.43%) is better than 68.25% of its industry peers.
  • In the last couple of years the Operating Margin of SGHC has declined.
Industry RankSector Rank
OM 15.43%
PM (TTM) 6.41%
GM N/A
OM growth 3Y-8.81%
OM growth 5YN/A
PM growth 3Y-28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGHC Yearly Profit, Operating, Gross MarginsSGHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SGHC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SGHC is creating value.
  • Compared to 1 year ago, SGHC has more shares outstanding
  • Compared to 5 years ago, SGHC has more shares outstanding
  • Compared to 1 year ago, SGHC has a worse debt to assets ratio.
SGHC Yearly Shares OutstandingSGHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SGHC Yearly Total Debt VS Total AssetsSGHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • SGHC has an Altman-Z score of 11.75. This indicates that SGHC is financially healthy and has little risk of bankruptcy at the moment.
  • SGHC has a better Altman-Z score (11.75) than 96.83% of its industry peers.
  • SGHC has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • SGHC's Debt to Equity ratio of 0.11 is fine compared to the rest of the industry. SGHC outperforms 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 11.75
ROIC/WACC3.86
WACC8.9%
SGHC Yearly LT Debt VS Equity VS FCFSGHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • SGHC has a Current Ratio of 1.58. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
  • SGHC has a Current ratio of 1.58. This is in the better half of the industry: SGHC outperforms 73.02% of its industry peers.
  • SGHC has a Quick Ratio of 1.58. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
  • SGHC's Quick ratio of 1.58 is fine compared to the rest of the industry. SGHC outperforms 76.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
SGHC Yearly Current Assets VS Current LiabilitesSGHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. SGHC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 140.49% over the past year.
  • The earnings per share for SGHC have been decreasing by -21.17% on average. This is quite bad
  • SGHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.20%.
  • The Revenue has been growing by 28.06% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)140.49%
EPS 3Y-21.17%
EPS 5YN/A
EPS Q2Q%102.5%
Revenue 1Y (TTM)18.2%
Revenue growth 3Y5.54%
Revenue growth 5Y28.06%
Sales Q2Q%-4.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 60.61% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 15.01% on average over the next years. This is quite good.
EPS Next Y111.34%
EPS Next 2Y91.33%
EPS Next 3Y60.61%
EPS Next 5YN/A
Revenue Next Year31.63%
Revenue Next 2Y22.6%
Revenue Next 3Y18.15%
Revenue Next 5Y15.01%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SGHC Yearly Revenue VS EstimatesSGHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
SGHC Yearly EPS VS EstimatesSGHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

5

4. SGHC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.86, SGHC is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of SGHC indicates a somewhat cheap valuation: SGHC is cheaper than 62.70% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.79, SGHC is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 14.33 indicates a correct valuation of SGHC.
  • Based on the Price/Forward Earnings ratio, SGHC is valued a bit cheaper than the industry average as 76.98% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 38.88. SGHC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 21.86
Fwd PE 14.33
SGHC Price Earnings VS Forward Price EarningsSGHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • SGHC's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.74
SGHC Per share dataSGHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of SGHC may justify a higher PE ratio.
  • A more expensive valuation may be justified as SGHC's earnings are expected to grow with 60.61% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y91.33%
EPS Next 3Y60.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. SGHC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.55%, SGHC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.04, SGHC pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, SGHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.55%

5.2 History

  • SGHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
SGHC Yearly Dividends per shareSGHC Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y91.33%
EPS Next 3Y60.61%
SGHC Yearly Income VS Free CF VS DividendSGHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

More info and screens

Find the best dividend stocksShow peers with best dividend

SGHC Fundamentals: All Metrics, Ratios and Statistics

SUPER GROUP SGHC LTD

NYSE:SGHC (4/22/2026, 8:04:00 PM)

After market: 12.25 +0.01 (+0.08%)

12.24

-0.16 (-1.29%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-03
Earnings (Next)05-06
Inst Owners19.12%
Inst Owner Change-0.02%
Ins Owners4.59%
Ins Owner Change-5.14%
Market Cap6.19B
Revenue(TTM)1.84B
Net Income(TTM)132.89M
Analysts84.29
Price Target17.72 (44.77%)
Short Float %8.71%
Short Ratio4.8
Dividend
Industry RankSector Rank
Dividend Yield 1.55%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date03-16
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.09%
Min EPS beat(2)-31.87%
Max EPS beat(2)27.7%
EPS beat(4)2
Avg EPS beat(4)-12.58%
Min EPS beat(4)-51.73%
Max EPS beat(4)27.7%
EPS beat(8)4
Avg EPS beat(8)76.53%
EPS beat(12)6
Avg EPS beat(12)116.21%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.17%
Min Revenue beat(2)8.12%
Max Revenue beat(2)10.23%
Revenue beat(4)3
Avg Revenue beat(4)5.25%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)10.23%
Revenue beat(8)6
Avg Revenue beat(8)5.18%
Revenue beat(12)10
Avg Revenue beat(12)6.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.42%
PT rev (3m)-1.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.99%
EPS NY rev (3m)-4.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 21.86
Fwd PE 14.33
P/S 2.99
P/FCF N/A
P/OCF N/A
P/B 9.31
P/tB 14.81
EV/EBITDA 14.74
EPS(TTM)0.56
EY4.58%
EPS(NY)0.85
Fwd EY6.98%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.1
BVpS1.32
TBVpS0.83
PEG (NY)0.2
PEG (5Y)N/A
Graham Number4.07076 (-66.74%)
Profitability
Industry RankSector Rank
ROA 11.9%
ROE 19.98%
ROCE 43.44%
ROIC 34.32%
ROICexc 73.64%
ROICexgc 263.12%
OM 15.43%
PM (TTM) 6.41%
GM N/A
FCFM N/A
ROA(3y)10.16%
ROA(5y)16.96%
ROE(3y)17.87%
ROE(5y)59.56%
ROIC(3y)15.79%
ROIC(5y)31.82%
ROICexc(3y)34.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.99%
ROCE(5y)40.28%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.96%
ROICexc growth 5YN/A
OM growth 3Y-8.81%
OM growth 5YN/A
PM growth 3Y-28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 0.17
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 11.75
F-ScoreN/A
WACC8.9%
ROIC/WACC3.86
Cap/Depr(3y)74.88%
Cap/Depr(5y)56.11%
Cap/Sales(3y)3.76%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)140.49%
EPS 3Y-21.17%
EPS 5YN/A
EPS Q2Q%102.5%
EPS Next Y111.34%
EPS Next 2Y91.33%
EPS Next 3Y60.61%
EPS Next 5YN/A
Revenue 1Y (TTM)18.2%
Revenue growth 3Y5.54%
Revenue growth 5Y28.06%
Sales Q2Q%-4.65%
Revenue Next Year31.63%
Revenue Next 2Y22.6%
Revenue Next 3Y18.15%
Revenue Next 5Y15.01%
EBIT growth 1Y202.71%
EBIT growth 3Y-3.76%
EBIT growth 5YN/A
EBIT Next Year136.41%
EBIT Next 3Y48.54%
EBIT Next 5Y34.33%
FCF growth 1Y142.01%
FCF growth 3Y-1.1%
FCF growth 5Y295.28%
OCF growth 1Y113.54%
OCF growth 3Y7.33%
OCF growth 5Y137.97%

SUPER GROUP SGHC LTD / SGHC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SUPER GROUP SGHC LTD (SGHC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SGHC.


Can you provide the valuation status for SUPER GROUP SGHC LTD?

ChartMill assigns a valuation rating of 5 / 10 to SUPER GROUP SGHC LTD (SGHC). This can be considered as Fairly Valued.


Can you provide the profitability details for SUPER GROUP SGHC LTD?

SUPER GROUP SGHC LTD (SGHC) has a profitability rating of 6 / 10.


What is the financial health of SUPER GROUP SGHC LTD (SGHC) stock?

The financial health rating of SUPER GROUP SGHC LTD (SGHC) is 5 / 10.